Alsaadi T, Suliman R, Yang J, Agarwal E, et al. A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine. Cephalalgia 2025;45:3331024251355947.
PMID: 40734466